Literature DB >> 25101131

Prevalence of Brucellosis among Women Presenting with Abortion/Stillbirth in Huye, Rwanda.

Nadine Rujeni1, Léonidas Mbanzamihigo2.   

Abstract

The incidence of human brucellosis is not documented in Rwanda despite several reports on the disease in cattle. Because brucellosis has been associated with abortion, the aim of this study was to investigate the prevalence of positive serology in women presenting with abortion and/or stillbirth. The study was done in Huye District, in the Southern Province of Rwanda, and the patients were recruited from both the University Teaching Hospital of Butare (CHUB) and Kabutare District Hospital. Serum samples were collected and the Rose Bengal plate test (RBPT) was performed on each sample. A questionnaire was also used to investigate potential contacts with animals and/or consumption of raw milk. A total of 60 women were recruited and 15 (i.e., 25%) were Brucella seropositive. The questionnaire showed that those with seropositivity either were in contact with domestic animals (cattle, goat, or sheep) or were consuming raw cow's milk. Human brucellosis appears to be of public health importance in Rwanda and more attention should be drawn on the disease. The current study provides a basis for larger studies to establish the incidence of human brucellosis in Rwanda. More mechanistic studies will also demonstrate the pathogenicity of Brucella in human placentas.

Entities:  

Year:  2014        PMID: 25101131      PMCID: PMC4101238          DOI: 10.1155/2014/740479

Source DB:  PubMed          Journal:  J Trop Med        ISSN: 1687-9686


1. Introduction

Brucellosis is a debilitating zoonotic disease due to bacteria of the genus Brucella. Infection is acquired either by contact with infected animals or consumption of contaminated milk or dairy products. The disease has major economic impact not only due to time lost by patients from normal daily activities but also due to the loss in animal husbandry [1, 2]. Indeed, brucellosis is characterised by abortion and loss of fertility in farm animals [2-4]. In humans, the symptomatology is not specific, and this makes the diagnostic quite challenging. Patients may present with an intermittent fever, joint pain (including arthritis), neurologic manifestations, and so forth [5]. The association between abortion/stillbirth and brucellosis in humans is controversial [6]. This could be due to the absence of erythritol (a 4-carbon sugar alcohol which is the preferred carbon source for Brucella) in human placentas as opposed to ruminant placentas [7, 8]. However, a recent study has demonstrated that Brucella replicates in several human trophoblast subpopulations and can interfere with the invasive capacity of extravillous trophoblast-like cells in vitro [9]. Studies investigating an association between human brucellosis and abortion in vivo are scarce. In Rwanda, the incidence of human brucellosis is not documented despite a number of reports on cattle brucellosis [10]. Because of the potential risk of Brucella-associated abortion in infected women, the aim of this study was to establish the seroprevalence of brucellosis in women presenting with abortion/stillbirth. This study also aims to document the risk factors for human brucellosis and the potential reservoir of pathogens.

2. Materials and Methods

2.1. Study Area and Population

The study was conducted in Huye District, located in the Southern Province of Rwanda. Blood samples were collected from women presenting with abortion/stillbirth of unknown cause at the district hospital (Kabutare) and the referral hospital (Butare University Teaching Hospital).

2.2. Ethical Statement

Permission to conduct the study was obtained from the medical director of each hospital as well as the head of department of the gynaecology and obstetrics. Institutional approval was obtained from the National University of Rwanda (currently part of the University of Rwanda). All the prospective study participants had the aims and procedures explained to them and only those who consented were enrolled into the study.

2.3. Sample Collection and Processing

Blood samples were collected into silicon-coated tubes without anticoagulant for isolation of sera. The blood was stored at 4°C overnight and centrifuged the following day and the serum was extracted. The Rose Bengal plate test (RBPT) was used to determine the seropositivity. Briefly, a drop of the Rose Bengal coloured Brucella antigen (TRANSAK, Belgium) was placed near a drop of serum on a clean slide placed on a white paper. The drops were then thoroughly mixed and observed after 4 minutes. If an agglutination reaction occurred, the sample was recorded as a positive case (and negative otherwise). The samples were collected from June to October 2006 and were processed all along. A total of 60 samples were collected and processed.

2.4. Questionnaires

A questionnaire was used to record demographic data (age, residency), clinical presentation (abortion, stillbirth), profession, and milk consumption habits.

2.5. Cattle Brucellosis

In order to determine the local prevalence of cattle brucellosis, records of brucellosis test results from 2 different farms were consulted. The first was the Kabutare farm, located within a veterinary school near the district hospital (Kabutare Hospital). The second was ISAR-Songa farm, part of a veterinary research institution in the Southern Province of Rwanda (ISAR-Songa is currently part of the Rwanda Agricultural Board). Randomly selected cows (from the local population) presenting at the Kabutare farm's abattoir were also tested for brucellosis during the study period. Blood samples (27 in total) were collected from the jugular vein and serum was extracted and processed as described in the previous paragraph (RBPT).

3. Results

3.1. Brucellosis Prevalence in Women

A total of sixty women were tested for brucellosis and 15 (25%) were positive as shown in Table 1. Eleven (11) of them (73.3%) had aborted while 4 (26.7%) presented with a stillbirth. The majority (76.7%) of tested women were between 18 and 33 years old.
Table 1

Prevalence of Brucella seropositivity by age group and clinical presentation.

Age range Total number of casesSeropositive casesPrevalence (%)
Clinical signs
AbortionStillbirthAbortionStillbirth
18–251534127.8
26–332176332
34–41821010
42–4931000
Total 47 13 11 4 25

The number of Brucella seropositive cases is shown for each age group.

Table 2 shows that 13 out of the 15 seropositive women (86.7%) consumed cow's milk, with 7 of them consuming it raw. Six of the 15 women (40%) were in regular contact with farm animals by profession (livestock-farming). Two of those in contact with livestock also consumed raw milk.
Table 2

Demographic characteristics of Brucella seropositive patients.

Characteristic n (%)
Age range18–49 years (median = 27)
Milk consumption 13 (86.7)
Occupation
 Livestock-farming6 (40)
 Farming6 (40)
 Other3 (20)

The age range of the study population and their occupation as well as the milk consumption rate are shown.

3.2. Prevalence in Cattle from Local Farms

Records from the Kabutare veterinary school's farm showed that the prevalence of brucellosis in cattle declined (9.6% to 4.6%) from the year 2002 to 2006 (see Table 3). These records were of tests done on cattle from the local population coming for insemination (natural or artificial).
Table 3

Brucellosis prevalence in cattle for a period of 5 years in the Kabutare veterinary school's farm.

YearPositive cases Total cases testedPrevalence (%)
RBPTRing test
200277481297 9.6
200310610322909.1
20041548362343.8
200517010769254
2006545423404.6

Results from brucellosis tests (RBPT or Ring test) routinely done before any natural or artificial insemination at the Kabutare veterinary school's farm (one of the main farms of the study area). RBPT: Rose Bengal plate test.

Twenty-seven (27) cows randomly selected from the Kabutare farm's abattoir were tested during the study period, and 2 cases (7.4%) were positive. Records from ISAR-Songa farm revealed that a single test was done on their livestock in 2004 and 50 cows out of 603 (8.3%) tested positive. According to the staff in charge of the livestock, these positive cases were isolated and progressively eliminated.

4. Discussion

The current study, conducted in Rwanda, revealed a high prevalence (25%) of human brucellosis among women presenting with either abortion or stillbirth. To our knowledge, this is the first study to document the presence of human brucellosis in Rwanda. Moreover, the study has shown that some cases of abortion/stillbirth may be due to this pathology in humans. A recent study has demonstrated that pathogenic Brucellae are able not only to proliferate in human trophoblasts but also to interfere with the invasive capacity of extravillous trophoblasts-like cells in vitro [9]. Findings from the current study, together with findings by Salcedo and colleagues, give insights into the otherwise controversial Brucella-associated abortion in humans [6]. The next step will be to isolate Brucella spp. from placental trophoblasts of aborting women. Results from the current study indicate that consumption of raw (cow's) milk, followed by contact with farm animals, is the main risk factor associated with Brucella seropositivity. This is consistent with findings from a study conducted in Iran, where 79% of infected patients contracted the disease via consumption of unpasteurized dairy products while 21% had a history of animal contact [11]. However, a lower prevalence of brucellosis in cattle (7.4%), with a declining trend in the local main farms, was observed in the current study. These findings suggest that milk from a single contaminated cow is consumed by more than one family. Moreover, while the tested cows were randomly selected, our study population was selected based on a suspicious symptomatology. The declining trend in cattle brucellosis from the consulted farms may be the result of control efforts in these institutions following documentations on cattle brucellosis [10]. There was no direct association between infected cattle and affected women in the current study as it was impossible to trace these cows specifically. However, the incidence in local farms is an indication on the local reservoir given the herds' movements and the trading of milk and dairy products. In conclusion, this study has shown that human brucellosis exists in Rwanda and that some cases of abortion/stillbirth may be associated with this pathology. Consumption of raw milk is the principal risk factor for contamination, followed by contact with farm animals. Education of the population regarding milk consumption habits could therefore extensively reduce the prevalence of infection. This study provides a basis for a larger study to document the national prevalence of human brucellosis (for control purposes) and calls for more mechanistic studies to link brucellosis and reproductive problems in humans.
  10 in total

1.  Foetal erythritol: a cause of the localization of Brucella abortus in bovine contagious abortion.

Authors:  H SMITH; A E WILLIAMS; J H PEARCE; J KEPPIE; P W HARRIS-SMITH; R B FITZ-GEORGE; K WITT
Journal:  Nature       Date:  1962-01-06       Impact factor: 49.962

2.  Erythritol catabolism by Brucella abortus.

Authors:  J F Sperry; D C Robertson
Journal:  J Bacteriol       Date:  1975-02       Impact factor: 3.490

3.  Novel replication profiles of Brucella in human trophoblasts give insights into the pathogenesis of infectious abortion.

Authors:  David O'Callaghan
Journal:  J Infect Dis       Date:  2013-01-09       Impact factor: 5.226

4.  Epidemiological, laboratory, diagnostic and public health aspects of human brucellosis in western Iran.

Authors:  Hamid Kassiri; Hamid Amani; Massoud Lotfi
Journal:  Asian Pac J Trop Biomed       Date:  2013-08

5.  Human health benefits from livestock vaccination for brucellosis: case study.

Authors:  Felix Roth; Jakob Zinsstag; Dontor Orkhon; G Chimed-Ochir; Guy Hutton; Ottorino Cosivi; Guy Carrin; Joachim Otte
Journal:  Bull World Health Organ       Date:  2004-03-01       Impact factor: 9.408

6.  Pathogenic brucellae replicate in human trophoblasts.

Authors:  Suzana Pinto Salcedo; Nicolas Chevrier; Thais Lourdes Santos Lacerda; Amira Ben Amara; Sarah Gerart; Vilma Arce Gorvel; Chantal de Chastellier; José Maria Blasco; Jean-Louis Mege; Jean-Pierre Gorvel
Journal:  J Infect Dis       Date:  2013-01-09       Impact factor: 5.226

Review 7.  Clinical manifestations of human brucellosis: a systematic review and meta-analysis.

Authors:  Anna S Dean; Lisa Crump; Helena Greter; Jan Hattendorf; Esther Schelling; Jakob Zinsstag
Journal:  PLoS Negl Trop Dis       Date:  2012-12-06

8.  Seroprevalence and potential risk factors for Brucella spp. infection in traditional cattle, sheep and goats reared in urban, periurban and rural areas of Niger.

Authors:  Abdou Razac Boukary; Claude Saegerman; Emmanuel Abatih; David Fretin; Rianatou Alambédji Bada; Reginald De Deken; Halimatou Adamou Harouna; Alhassane Yenikoye; Eric Thys
Journal:  PLoS One       Date:  2013-12-16       Impact factor: 3.240

Review 9.  Retrospective and prospective perspectives on zoonotic brucellosis.

Authors:  Edgardo Moreno
Journal:  Front Microbiol       Date:  2014-05-13       Impact factor: 5.640

10.  Brucellosis seroprevalence in Bali cattle with reproductive failure in South Sulawesi and Brucella abortus biovar 1 genotypes in the Eastern Indonesian archipelago.

Authors:  Hanah Muflihanah; Mochammad Hatta; Ente Rood; Pauline Scheelbeek; Theresia H Abdoel; Henk L Smits
Journal:  BMC Vet Res       Date:  2013-11-26       Impact factor: 2.741

  10 in total
  9 in total

1.  Seroprevalence of Brucellosis among Patients Attending a District Hospital in Rwanda.

Authors:  James Gafirita; George Kiiza; Angelique Murekatete; Leonard L Ndahayo; John Tuyisenge; Vedaste Mashengesho; Rudoviko Ruhirwa; Theogene Nyandwi; Brenda Asiimwe-Kateera; Vedaste Ndahindwa; Kato J Njunwa
Journal:  Am J Trop Med Hyg       Date:  2017-07-27       Impact factor: 2.345

2.  Human Brucellosis and Adverse Pregnancy Outcomes.

Authors:  Angela M Arenas-Gamboa; Carlos A Rossetti; Sankar P Chaki; Daniel G Garcia-Gonzalez; Leslie G Adams; Thomas A Ficht
Journal:  Curr Trop Med Rep       Date:  2016-10-01

3.  Brucellosis in pregnant women from Pakistan: an observational study.

Authors:  Shahzad Ali; Shamim Akhter; Heinrich Neubauer; André Scherag; Miriam Kesselmeier; Falk Melzer; Iahtasham Khan; Hosny El-Adawy; Asima Azam; Saima Qadeer; Qurban Ali
Journal:  BMC Infect Dis       Date:  2016-09-02       Impact factor: 3.090

4.  Predominance of Brucella abortus antibodies among women with spontaneous abortion in the city of Mwanza: unrecognized link or coincidence?

Authors:  Fridolin Mujuni; Venance Andrew; Elifuraha B Mngumi; Elieza Chibwe; Stephen E Mshana; Mariam M Mirambo
Journal:  BMC Res Notes       Date:  2018-11-06

5.  Brucella abortus Infection of Placental Trophoblasts Triggers Endoplasmic Reticulum Stress-Mediated Cell Death and Fetal Loss via Type IV Secretion System-Dependent Activation of CHOP.

Authors:  Mariana X Byndloss; April Y Tsai; Gregory T Walker; Cheryl N Miller; Briana M Young; Bevin C English; Núbia Seyffert; Tobias Kerrinnes; Maarten F de Jong; Vidya L Atluri; Maria G Winter; Jean Celli; Renée M Tsolis
Journal:  mBio       Date:  2019-07-23       Impact factor: 7.867

Review 6.  Different Clinical Manifestations of Human Brucellosis in Pregnant Women: A Systematic Scoping Review of 521 Cases from 10 Countries.

Authors:  Zhe Liu; Dawei Wei; Yanjun Li; Hao Zhou; Desheng Huang; Peng Guan
Journal:  Infect Drug Resist       Date:  2020-04-14       Impact factor: 4.003

7.  Community-based prevalence of typhoid fever, typhus, brucellosis and malaria among symptomatic individuals in Afar Region, Ethiopia.

Authors:  Biruk Zerfu; Girmay Medhin; Gezahegne Mamo; Gezahegn Getahun; Rea Tschopp; Mengistu Legesse
Journal:  PLoS Negl Trop Dis       Date:  2018-10-04

Review 8.  Human brucellosis in pregnancy - an overview.

Authors:  Mile Bosilkovski; Jurica Arapović; Fariba Keramat
Journal:  Bosn J Basic Med Sci       Date:  2020-11-02       Impact factor: 3.363

9.  Sero-prevalence and risk factors of Brucella presence in farm bulk milk from open and zero grazing cattle production systems in Rwanda.

Authors:  Juvenal Djangwani; George Ooko Abong'; Lucy Gicuku Njue; Dasel Wambua Mulwa Kaindi
Journal:  Vet Med Sci       Date:  2021-07-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.